Advanced Search:

QDEL - Quidel

$42.17  -0.81 (-1.88%)

Updated: 03:11 May 5, 2024 EST

Next Hour's AI Forecast

99.62%

Avg. Accuracy (AI)

$43.76

Next Session's AI Forecast

95.52%

Avg. Accuracy (AI)

$43.48

Next Week's AI Forecast

16.67%

Trend's Accuracy (AI)

$40.97

Quidel's Position Within the Medical Devices Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

QUIDEL - HISTORICAL DATA 6M

  • Last price

    $ 42.17

  • Daily change

    $ -0.81

  • Previous Close

    $ 42.98

  • Last Updated

    03:11 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
3.07 0.01 -0.71 -0.28 -0.29

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
3.07 2.17 3.1 2.37 2

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 100% 80.85% 16.46%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
43.65 6.99% 40.8 -4.7% 42.81 -26.05% 57.89

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.42 50.74 2.85 29.58

Quidel Technical Analysis News

Quidel

9975 Summers Ridge Road
San Diego, CA 92121
United States
858 552 1100
https://www.quidelortho.com

Sectors: Healthcare
Industry: Medical Devices
F. Time Employees: 7100
Description

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

Corporate Governance

QuidelOrtho Corporation’s ISS Governance QualityScore as of May 1, 2024 is 3. The pillar scores are Audit: 3; Board: 2; Shareholder Rights: 4; Compensation: 5.

QUIDEL'S HOLDERS RANK

List of holders with stock participation in Quidel.